These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9435550)

  • 1. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2.
    Drucker DJ; DeForest L; Brubaker PL
    Am J Physiol; 1997 Dec; 273(6):G1252-62. PubMed ID: 9435550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factor regulation of PC4/TIS7, an immediate early gene expressed during gut adaptation after resection.
    Swietlicki E; Iordanov H; Fritsch C; Yi L; Levin MS; Rubin DC
    JPEN J Parenter Enteral Nutr; 2003; 27(2):123-31. PubMed ID: 12665168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
    Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome.
    Lim DW; Levesque CL; Vine DF; Muto M; Koepke JR; Nation PN; Wizzard PR; Li J; Bigam DL; Brubaker PL; Turner JM; Wales PW
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G390-G404. PubMed ID: 28104586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide 2 is a potent growth factor for small intestine and colon.
    Litvak DA; Hellmich MR; Evers BM; Banker NA; Townsend CM
    J Gastrointest Surg; 1998; 2(2):146-50. PubMed ID: 9834410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2.
    Brubaker PL; Izzo A; Hill M; Drucker DJ
    Am J Physiol; 1997 Jun; 272(6 Pt 1):E1050-8. PubMed ID: 9227451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
    Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
    Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV.
    Drucker DJ; Shi Q; Crivici A; Sumner-Smith M; Tavares W; Hill M; DeForest L; Cooper S; Brubaker PL
    Nat Biotechnol; 1997 Jul; 15(7):673-7. PubMed ID: 9219272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological determinants of intestinotrophic properties of GLP-2 in vivo.
    Tsai CH; Hill M; Drucker DJ
    Am J Physiol; 1997 Mar; 272(3 Pt 1):G662-8. PubMed ID: 9124589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial cell growth and differentiation. I. Intestinal growth factors.
    Drucker DJ
    Am J Physiol; 1997 Jul; 273(1 Pt 1):G3-6. PubMed ID: 9252503
    [No Abstract]   [Full Text] [Related]  

  • 11. GLP-2, EGF, and the Intestinal Epithelial IGF-1 Receptor Interactions in the Regulation of Crypt Cell Proliferation.
    Fesler Z; Mitova E; Brubaker PL
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32147716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
    Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
    Liu X; Murali SG; Holst JJ; Ney DM
    Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor.
    Kitchen PA; Goodlad RA; FitzGerald AJ; Mandir N; Ghatei MA; Bloom SR; Berlanga-Acosta J; Playford RJ; Forbes A; Walters JR
    JPEN J Parenter Enteral Nutr; 2005; 29(4):248-54. PubMed ID: 15961680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats.
    Steeb CB; Trahair JF; Read LC
    Gut; 1995 Nov; 37(5):630-8. PubMed ID: 8549937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous GLP-2 and IGF-I induce a differential intestinal response in IGF binding protein-3 and -5 double knockout mice.
    Murali SG; Brinkman AS; Solverson P; Pun W; Pintar JE; Ney DM
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G794-804. PubMed ID: 22281475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teduglutide ([Gly2]GLP-2) protects small intestinal stem cells from radiation damage.
    Booth C; Booth D; Williamson S; Demchyshyn LL; Potten CS
    Cell Prolif; 2004 Dec; 37(6):385-400. PubMed ID: 15548172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartame supplementation in starter accelerates small intestinal epithelial cell cycle and stimulates secretion of glucagon-like peptide-2 in pre-weaned lambs.
    Sun D; Liu L; Mao S; Zhu W; Liu J
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1338-1350. PubMed ID: 31342562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.
    Shin ED; Estall JL; Izzo A; Drucker DJ; Brubaker PL
    Gastroenterology; 2005 May; 128(5):1340-53. PubMed ID: 15887116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.